Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-01-26 @ 6:13 PM
Study NCT ID:
NCT01973218
Status:
COMPLETED
Last Update Posted:
2015-10-30
First Post:
2013-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years.
Sponsor:
Novartis Vaccines
Organization: